Brief: Sensorion Presents New Preclinical Data On SENS-401 At ARO 2021

Sensorion SA

19/02/2021 07:33

Feb 19 (Reuters) - SENSORION SA  ALSEN.PA :
    * SENSORION PRESENTS NEW PRECLINICAL DATA ON SENS-401 AT ARO
2021
    * SENS-401 IS SENSORION'S LEAD SMALL MOLECULE PRODUCT, IN
PHASE 2
CLINICAL TRIAL FOR SSNHL AND WITH A SECOND CLINICAL TRIAL TO
LAUNCH IN 2H 2021 FOR TREATMENT OF CISPLATIN-INDUCED OTOTOXICITY
(CIO)

Source text for Eikon:  ID:nBw3yQ8Vxa 
Further company coverage:  ALSEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))